The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO Italy 2020 | Italian perspective: managing DLBCL
Gerardo Musuraca, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, outlines the Italian perspective of the diagnosis, treatment, and management of diffuse large B-cell lymphoma (DLBCL) including understanding molecular alterations involved in the pathogenesis of disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
